A randomized, multi-center, double-blind, double-dummy, parallel-group, 8 week pilot study, to investigate the effect of QMF Twisthaler (250/400 microg q.d. evening) compared to fluticasone propionate/salmeterol (250/50 microg b.i.d.) FSC in patients with Chronic Obstructive Pulmonary Disease (COPD).
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2012
At a glance
- Drugs Indacaterol/mometasone; Salmeterol/fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 08 Aug 2011 This trial is recruiting in Spain and Slovakia, and has completed in Czech Republic.
- 05 Aug 2011 New trial record